Clinical Trial Update: Use of NexoBrid for Treatment of Acute Deep Partial and Full Thickness Burn Injuries

View source ↗

Summary

MediWound's NexoBrid has received marketing approval for the treatment of acute deep partial-thickness and full-thickness burn injuries caused by thermal burns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• NEXOBRID (ANACAULASE-BCDB)

Snippet

Sponsor: MediWound Ltd | Conditions: Thermal Burn | Status: APPROVED_FOR_MARKETING